DCGI

‘Sputnik, AstraZeneca mix & match results by end of July’ | India News

NEW DELHI: Russian Direct Investment Fund (RDIF) is expecting to release the results of Sputnik V and Astra-Zeneca ‘mix and match’ vaccine by the end of July. In a press briefing, Kirill Dmitriev, CEO, RDIF informed that high efficacy is expected from the trials. “This approach has been really pioneered by Sputnik V in the …

‘Sputnik, AstraZeneca mix & match results by end of July’ | India News Read More »

Serum Institute to start manufacturing Sputnik vaccine in September | India News

NEW DELHI: Serum Institute of India (SII) will start production of Sputnik vaccine at the company’s facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday. “The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September,” RDIF said in a statement. The parties intend to produce over 300 …

Serum Institute to start manufacturing Sputnik vaccine in September | India News Read More »

In a first, 5 Indian pharma majors ally for Covid drug trials | India News

HYDERABAD: In a first, five Indian pharma majors have joined hands to conduct phase-III clinical trials of investigational anti-viral drug Molnupiravir on mild Covid-19 patients. The companies include Dr Reddy’s Laboratories Ltd, Cipla Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd and Emcure Pharmaceuticals Ltd. The companies have entered into a collaboration agreement, as part …

In a first, 5 Indian pharma majors ally for Covid drug trials | India News Read More »

DCGI gives emergency use nod to Moderna’s vaccine | India News

Indian pharma major Cipla will “facilitate” the import of Covid vaccines donated by US biotech major Moderna, possibly in the near future, under licence for restricted use by India’s drug regulator DCGI. In parallel, Cipla is also pursuing a separate tie-up with the US firm to undertake large-scale fill-and-finish, distribution and commercialisation of Moderna’s messenger …

DCGI gives emergency use nod to Moderna’s vaccine | India News Read More »

Covid: In a first, 5 Indian pharma majors join hands for Molnupiravir clinical trials | India News

HYDERABAD: In a first such instance of collaboration in the pharma sector, five Indian pharma majors – Cipla Ltd, Dr Reddy’s Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd, Emcure Pharmaceuticals – have joined hands for conducting the clinical trial of investigational oral anti-viral drug Molnupiravir for the treatment of mild Covid-19 in an …

Covid: In a first, 5 Indian pharma majors join hands for Molnupiravir clinical trials | India News Read More »

Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India: Sources | India News

NEW DELHI: India’s drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna‘s Covid-19 vaccine for restricted emergency use in the country, official sources said on Tuesday. Moderna’s vaccine will be the fourth Covid-19 jab to be available in India after Covishield, Covaxin and Sputnik. “Drugs Controller General of India (DCGI) …

Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India: Sources | India News Read More »